Elanco Animal Health Incorporated

Elanco Animal Health Incorporated is a global leader dedicated to innovating, developing, manufacturing, and marketing a comprehensive portfolio of products designed to enhance the health and well-being of both companion animals and food-producing livestock. For pets, Elanco offers a wide array of solutions including parasiticides, vaccines, and therapeutics aimed at protecting against fleas, ticks, and internal parasites, as well as treatments for pain, otitis, cardiovascular, dermatology, and osteoarthritis. Key brands in the pet health segment include Seresto, Credelio, Interceptor Plus, and Galliprant. In the farm animal sector, Elanco provides essential products that help producers improve animal health, welfare, and productivity in cattle, swine, and poultry operations. This includes medicated feed additives, injectable antibiotics, vaccines, insecticides, and enzymes, with prominent brands such as Rumensin, Baytril, Experior, and AviPro. Elanco’s business model leverages a dual distribution strategy, reaching customers through third-party distributors and independent retailers, as well as directly engaging with farm animal producers and veterinarians. This approach ensures broad market access and supports its strategic focus on addressing unmet needs in animal health through science-driven innovation and a commitment to improving the lives of animals and the people who care for them.